Skip to main content
Premium Trial:

Request an Annual Quote

Radiomics, OncoDNA Partner to ID Lung Cancer Biomarkers

NEW YORK – Radiomics and OncoDNA on Monday said they will combine the two companies' expertise in machine learning-enabled analysis of medical images and molecular biomarker evaluation to improve the biological understanding and treatment of non-small cell lung cancer.

The two Belgian firms will collaborate within the prospective Measure Lung Cancer Biology and Treatment Response via Imaging trial, dubbed SALMON for short, in which Radiomics is hoping to validate its artificial intelligence-based medical imaging analysis technology and create a "radiomics atlas of oncogenic biomarkers." In this trial, which will begin recruiting patients in multiple countries starting next year, researchers are collecting biopsy samples and imaging data from NSCLC patients and will analyze oncogenic features and therapy response in tomography and CT scans.

The latest collaboration will bring in OncoDNA's molecular biomarker analysis capabilities into the trial. OncoDNA will sequence NSCLC patients' tissue and blood samples in the SALMON trial and track disease progression using biomarkers in circulating tumor DNA.

"We believe pairing Radiomics science with our technology platform will prove the value of combining technologies and result in a major step ahead for the development of new solutions for cancer treatment," OncoDNA CEO Bernard Courtieu said in a statement.

The Scan

Nucleotide Base Detected on Near-Earth Asteroid

Among other intriguing compounds, researchers find the nucleotide uracil, a component of RNA sequences, in samples collected from the near-Earth asteroid Ryugu, as they report in Nature Communications.

Clinical Trial Participants, Investigators Point to Importance of Clinical Trial Results Reporting in Canadian Study

Public reporting on clinical trial results is crucial, according to interviews with clinical trial participants, investigators, and organizers from three provinces appearing in BMJ Open.

Old Order Amish Analysis Highlights Autozygosity, Potential Ties to Blood Measures

Researchers in BMC Genomics see larger and more frequent runs-of-homozygosity in Old Order Amish participants, though only regional autozygosity coincided with two blood-based measures.

Suicidal Ideation-Linked Loci Identified Using Million Veteran Program Data

Researchers in PLOS Genetics identify risk variants within and across ancestry groups with a genome-wide association study involving veterans with or without a history of suicidal ideation.